Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer

In a phase I study we demonstrated the feasibility of a bi-weekly combination of paclitaxel 180 mg m(−2) with cisplatin 60 mg m(−2). In this study we further assessed toxicity and efficacy of this schedule in the treatment of advanced cancer of the oesophagus or the gastro-oesophageal junction. Pati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Polee, M B, Eskens, F A L M, van der Burg, M E L, Splinter, T A W, Siersema, P D, Tilanus, H W, Verweij, J, Stoter, G, van der Gaast, A
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2002
Matèries:
Clinical
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2375296/
https://ncbi.nlm.nih.gov/pubmed/11875723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600166
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars